- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2009 (2009), Article ID 805709, 11 pages
Activation of Cyclin-Dependent Kinase 5 Is a Consequence of Cell Death
1Department of Biology, Queens College and Graduate Center of the City University of New York, Flushing, NY 11367, USA
2Department of Technology and Health, Higher Institute for Health, 00161 Rome, Italy
3Department of Drug Research and Evaluation, Highest Institute for Health, 00161 Rome, Italy
4Department of Biological Sciences, St. John's University, Jamaica, NY 11439, USA
Received 28 April 2009; Revised 20 June 2009; Accepted 14 July 2009
Academic Editor: Mauro Piacentini
Copyright © 2009 Yixia Ye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L.-H. Tsai, T. Takahashi, V. S. Caviness Jr., and E. Harlow, “Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system,” Development, vol. 119, no. 4, pp. 1029–1040, 1993.
- J. Lew, R. J. Winkfein, H. K. Paudel, and J. H. Wang, “Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2,” The Journal of Biological Chemistry, vol. 267, no. 36, pp. 25922–25926, 1992.
- F. A. Dhariwala and M. S. Rajadhyaksha, “An unusual member of the Cdk family: Cdk5,” Cellular and Molecular Neurobiology, vol. 28, no. 3, pp. 351–369, 2008.
- Y. Hirota, T. Ohshima, N. Kaneko, et al., “Cyclin-dependent kinase 5 is required for control of neuroblast migration in the postnatal subventricular zone,” Journal of Neuroscience, vol. 27, no. 47, pp. 12829–12838, 2007.
- L. Connell-Crowley, M. Le Gall, D. J. Vo, and E. Giniger, “The cyclin-dependent kinase Cdk5 controls multiple aspects of axon patterning in vivo,” Current Biology, vol. 10, no. 10, pp. 599–602, 2000.
- S. Rakić, C. Davis, Z. Molnár, M. Nikolić, and J. G. Parnavelas, “Role of p35/Cdk5 in preplate splitting in the developing cerebral cortex,” Cerebral Cortex, vol. 16, supplement 1, pp. i35–i45, 2006.
- J. L. Rosales, J. D. Ernst, J. Hallows, and K.-Y. Lee, “GTP-dependent secretion from neutrophils is regulated by Cdk5,” The Journal of Biological Chemistry, vol. 279, no. 52, pp. 53932–53936, 2004.
- R. Homayouni and T. Curran, “Cortical development: Cdk5 gets into sticky situations,” Current Biology, vol. 10, no. 9, pp. R331–R334, 2000.
- Y. Miyamoto, J. Yamauchi, J. R. Chan, et al., “Cdk5 regulates differentiation of oligodendrocyte precursor cells through the direct phosphorylation of paxillin,” Journal of Cell Science, vol. 120, no. 24, pp. 4355–4366, 2007.
- A. H. Hawasli and J. A. Bibb, “Alternative roles for Cdk5 in learning and synaptic plasticity,” Biotechnology Journal, vol. 2, no. 8, pp. 941–948, 2007.
- X. Xin, F. Ferraro, N. Bäck, B. A. Eipper, and R. E. Mains, “Cdk5 and Trio modulate endocrine cell exocytosis,” Journal of Cell Science, vol. 117, no. 20, pp. 4739–4748, 2004.
- E.-A. Choe, L. Liao, J.-Y. Zhou, et al., “Neuronal morphogenesis is regulated by the interplay between cyclin-dependent kinase 5 and the ubiquitin ligase mind bomb 1,” Journal of Neuroscience, vol. 27, no. 35, pp. 9503–9512, 2007.
- Y. Feng and C. A. Walsh, “Protein-protein interactions, cytoskeletal regulation and neuronal migration,” Nature Reviews Neuroscience, vol. 2, no. 6, pp. 408–416, 2001.
- J. C. Cruz and L.-H. Tsai, “Cdk5 deregulation in the pathogenesis of Alzheimer's disease,” Trends in Molecular Medicine, vol. 10, no. 9, pp. 452–458, 2004.
- Q. Guo, “When good Cdk5 turns bad,” Science of Aging Knowledge Environment, vol. 2006, no. 5, article pe5, 2006.
- J. Zhang and G. V. W. Johnson, “Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells,” Journal of Neurochemistry, vol. 75, no. 6, pp. 2346–2357, 2000.
- Q. Zhang, H. S. Ahuja, Z. Zakeri, and D. J. Wolgemuth, “Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling,” Developmental Biology, vol. 183, no. 2, pp. 222–233, 1997.
- Z. H. Cheung, A. K. Y. Fu, and N. Y. Ip, “Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases,” Neuron, vol. 50, no. 1, pp. 13–18, 2006.
- T. Sandal, C. Stapnes, H. Kleivdal, L. Hedin, and S. O. Døskeland, “A novel, extraneuronal role for cyclin-dependent protein kinase 5 (CDK5): modulation of cAMP-induced apoptosis in rat leukemia cells,” The Journal of Biological Chemistry, vol. 277, no. 23, pp. 20783–20793, 2002.
- Y. Zhu, L. Lin, S. Kim, D. Quaglino, R. A. Lockshin, and Z. Zakeri, “Cyclin dependent kinase 5 and its interacting proteins in cell death induced in vivo by cyclophosphamide in developing mouse embryos,” Cell Death and Differentiation, vol. 9, no. 4, pp. 421–430, 2002.
- J. L. Rosales and K.-Y. Lee, “Extraneuronal roles of cyclin-dependent kinase 5,” BioEssays, vol. 28, no. 10, pp. 1023–1034, 2006.
- A. K. Upadhyay, A. K. Ajay, S. Singh, and M. K. Bhat, “Cell cycle regulatory protein 5 (cdk5) is a novel downstream target of ERK in carboplatin induced death of breast cancer cells,” Current Cancer Drug Targets, vol. 8, no. 8, pp. 741–752, 2008.
- H. S. Ahuja, W. James, and Z. Zakeri, “Rescue of the limb deformity in hammertoe mutant mice by retinoic acid-induced cell death,” Developmental Dynamics, vol. 208, no. 4, pp. 466–481, 1997.
- F. Gao, U. Jütting, K. Rodenacker, P. Gais, and P.-Z. Lin, “Relevance of chromatin features in the progression of esophageal epithelial severe dysplasia,” Analytical Cellular Pathology, vol. 13, no. 1, pp. 17–28, 1997.
- L. Lin, Y. Ye, and Z. Zakeri, “P53, Apaf-1, caspase-3, and -9 are dispensable for Cdk5 activation during cell death,” Cell Death and Differentiation, vol. 13, no. 1, pp. 141–150, 2006.
- L. Cagnon and O. Braissant, “Role of caspases, calpain and cdk5 in ammonia-induced cell death in developing brain cells,” Neurobiology of Disease, vol. 32, no. 2, pp. 281–292, 2008.
- M. Slevin and J. Krupinski, “Cyclin-dependent kinase-5 targeting for ischaemic stroke,” Current Opinion in Pharmacology, vol. 9, no. 2, pp. 119–124, 2009.
- P. Paoletti, I. Vila, M. Rifé, J. M. Lizcano, J. Alberch, and S. Ginés, “Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5,” Journal of Neuroscience, vol. 28, no. 40, pp. 10090–10101, 2008.
- L.-H. Teai, I. Delalle, V. S. Cavness Jr., T. Chae, and E. Harlow, “p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5,” Nature, vol. 371, no. 6496, pp. 419–423, 1994.
- D. Tang, J. Yeung, K.-Y. Lee, et al., “An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator,” The Journal of Biological Chemistry, vol. 270, no. 45, pp. 26897–26903, 1995.
- R. Donnellan and R. Chetty, “Cyclin E in human cancers,” The FASEB Journal, vol. 13, no. 8, pp. 773–780, 1999.
- A. Dinarina, L. H. Perez, A. Davila, M. Schwab, T. Hunt, and A. R. Nebreda, “Characterization of a new family of cyclin-dependent kinase activators,” Biochemical Journal, vol. 386, no. 2, pp. 349–355, 2005.
- D. I. Orellana, R. A. Quintanilla, and R. B. Maccioni, “Neuroprotective effect of TNF against the -amyloid neurotoxicity mediated by CDK5 kinase,” Biochimica et Biophysica Acta, vol. 1773, no. 2, pp. 254–263, 2007.
- U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970.
- K.-H. Sun, Y. de Pablo, F. Vincent, and K. Shah, “Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction,” Journal of Neurochemistry, vol. 107, no. 1, pp. 265–278, 2008.
- E. J. Morris, E. Keramaris, H. J. Rideout, et al., “Cyclin-dependent kinases and p53 pathways are activated independently and mediate Bax activation in neurons after DNA damage,” Journal of Neuroscience, vol. 21, no. 14, pp. 5017–5026, 2001.
- A. R. Nebreda, “CDK activation by non-cyclin proteins,” Current Opinion in Cell Biology, vol. 18, no. 2, pp. 192–198, 2006.
- T. Hayashi, M. Sakurai, K. Abe, and Y. Itoyama, “DNA fragmentation precedes aberrant expression of cell cycle-related protein in rat brain after MCA occlusion,” Neurological Research, vol. 21, no. 7, pp. 695–698, 1999.
- B.-S. Li, L. Zhang, S. Takahashi, et al., “Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3,” The EMBO Journal, vol. 21, no. 3, pp. 324–333, 2002.
- J. H. Weishaupt, L. Kussmaul, P. Grötsch, et al., “Inhibition of CDK5 is protective in necrotic and apoptotic paradigms of neuronal cell death and prevents mitochondrial dysfunction,” Molecular and Cellular Neuroscience, vol. 24, no. 2, pp. 489–502, 2003.